Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology
- PMID: 10673750
- DOI: 10.1038/sj.leu.2401645
Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology
Abstract
We applied a new strategy for the detection of N-ras gene mutations based on LightCycler technology. We designed two sets of amplimers and internal hybridization probes representing N-ras codons 12/13 and codon 61, respectively. Genomic DNAs from 134 childhood acute lymphoblastic leukemia (ALL) patients (83 common ALL, nine pre-pre-B ALL, 19 pre-B ALL, 23 T-ALL) were amplified, followed by the analysis of the melting temperatures of the PCR products on the LightCycler. PCR products exhibiting an abnormal melting characteristic were directly sequenced. Sequence analyses unravelled nucleotide substitutions at codon 12 in 10 patients, at codon 13 in three, and at codon 61 in one case. The incidence of N-rasmutations (10%) is compatible with previous reports. The LightCycler technology facilitates the rapid analysis of other genes exhibiting hot spot mutations in human malignancies.
Similar articles
-
Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases.Int J Hematol. 1998 Jun;67(4):379-87. doi: 10.1016/s0925-5710(98)00015-2. Int J Hematol. 1998. PMID: 9695411
-
Lack of association between N-ras gene mutations and clinical prognosis in Brazilian children with acute lymphoblastic leukemia.Leuk Lymphoma. 2001 Jul;42(3):473-9. doi: 10.3109/10428190109064604. Leuk Lymphoma. 2001. PMID: 11699412
-
Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.Blood. 1995 May 1;85(9):2546-52. Blood. 1995. PMID: 7727782
-
Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia.Leukemia. 2000 Feb;14(2):316-23. doi: 10.1038/sj.leu.2401655. Leukemia. 2000. PMID: 10673751
-
RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia.Leukemia. 1995 Mar;9(3):466-70. Leukemia. 1995. PMID: 7885045
Cited by
-
Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity.Leuk Lymphoma. 2012 Sep;53(9):1839-41. doi: 10.3109/10428194.2012.663916. Epub 2012 Mar 13. Leuk Lymphoma. 2012. PMID: 22303899 Free PMC article. No abstract available.
-
Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).Tumour Biol. 2013 Feb;34(1):521-9. doi: 10.1007/s13277-012-0577-y. Epub 2012 Nov 13. Tumour Biol. 2013. PMID: 23150177
-
Genetic aberrations in childhood acute lymphoblastic leukaemia: application of high-density single nucleotide polymorphism array.Malays J Med Sci. 2010 Jul;17(3):5-12. Malays J Med Sci. 2010. PMID: 22135543 Free PMC article.
-
Murine leukemia virus proviral insertions between the N-ras and unr genes in B-cell lymphoma DNA affect the expression of N-ras only.J Virol. 2001 Dec;75(23):11907-12. doi: 10.1128/JVI.75.23.11907-11912.2001. J Virol. 2001. PMID: 11689675 Free PMC article.
-
Identification of Wee1 as a novel therapeutic _target for mutant RAS-driven acute leukemia and other malignancies.Leukemia. 2015 Jan;29(1):27-37. doi: 10.1038/leu.2014.149. Epub 2014 May 5. Leukemia. 2015. PMID: 24791855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous